NEXT Oncology Hospital Quironsalud

Madrid 28223

1 studies enrolling now · 1 studies all time

What they study most

Hormone Receptor Positive HER-2 Negative Breast Cancer, Hormone Receptor-positive Breast Cancer, Metastatic Breast Cancer

Studies at this site

• Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer — Recruiting now